Skip to main content
GANX logo

GANX · Gain Therapeutics, Inc. · Holdings

Track GANX — free
$1.64 +0.03 (+1.55%) At close · Oct 9
Market Cap
$71.58M
Shares
43.64M
Volume · Oct 9 328.69K Avg daily vol (3M) 491.88K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 50
Total Value: $17,831,865
Total Shares: 8,786,175

Institutional Ownership Trend

23 quarters

Holder Concentration

Across 50 13F filers
Top Holder
21.8%
Sep 2023 → Jun 2026 · range 15.6% – 38.7%
of institutional value
Top 5
53.1%
Sep 2023 → Jun 2026 · range 53.1% – 83.2%
of institutional value
Top 10
75.9%
Sep 2023 → Jun 2026 · range 75.9% – 96.4%
of institutional value
HHI
883
Sep 2023 → Jun 2026 · range 834 – 1,921
Broadly held
Showing 54 of 54
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1819411 CUSIP 36269B105 13F (30d) 2 filings 2 filers Visit website Investor relations